Skip to main content

FDA Updates

First EGFR Mutation Blood Test Approved for Patients with NSCLC

Atezolizumab Approved for Patients with Advanced or Metastatic Urothelial Carcinoma

Nivolumab Approved for Patients with Relapsed, Refractory Classical Hodgkin Lymphoma

Lenvatinib Approved for Use with Everolimus for Treating Advanced Renal Cell Carcinoma

Keytruda (Pembrolizumab): First PD-1 Inhibitor Approved for the Treatment of Patients with Metastatic Non–Small-Cell Lung Cancer Expressing PD-L1

A Pipeline Preview of 2016 FDA Approvals in Hematology/Oncology

Zarxio (Filgrastim-sndz): First Biosimilar Approved in the United States

Varubi (Rolapitant) Approved for the Prevention of Delayed-Onset Chemotherapy-Induced Nausea and Vomiting

Revlimid (Lenalidomide) Now FDA Approved as First-Line Therapy for Patients with Multiple Myeloma

Portrazza (Necitumumab), an IgG1 Monoclonal Antibody, FDA Approved for Advanced Squamous Non–Small-Cell Lung Cancer

25
26
27
28
29
30
31

Page 28 of 33
Results 271 - 280 of 330